Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Multiple Sclerosis

Free Subscription 24.08.2026 1 Acta Neuropathol 1 Brain 3 J Neurol 1 J Neurol Sci 8 Mult Scler 5 Neurology 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. ABBADESSA G, Kreft KL, Howell O, de Oliveira JVC, et al
   Genetic subtypes of multiple sclerosis severity are uncoupled from inflammatory lesion burden.
   Acta Neuropathol. 2026;152:24.
   PubMed         Abstract available
   
   

   
   Brain

2. SORMANI MP, Wiendl H, Montalban X, Oh J, et al
   Rethinking multiple sclerosis therapy beyond clinical phenotypes.
   Brain. 2026 Aug 18:awag273. doi: 10.1093.
   PubMed        
   
   

   
   J Neurol

3. GABELIC T, Tesija K, Sredanovic M, Adamec I, et al
   Persistent B-cell depletion after ublituximab for multiple sclerosis.
   J Neurol. 2026;273:536.
   PubMed        
   
   
4. FOURNET A, Munsch F, Koubiyr I, Vidal JP, et al
   Interthalamic adhesion alterations in multiple sclerosis: associations with thalamic damage and cognition.
   J Neurol. 2026;273:535.
   PubMed         Abstract available
   
   
5. BROCHET B, Moreau T, Saubusse A, Charre-Morin J, et al
   Episodic memory deficits are associated with social cognitive impairments in multiple sclerosis.
   J Neurol. 2026;273:534.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

6. KARADENIZ M, Wesselingh R, Butzkueven H, Monif M, et al
   Response to the commentary on - Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.
   J Neurol Sci. 2026;490:126127.
   PubMed        
   
   

   
   Mult Scler

7. RUIZ-ARGUELLES GJ
   Additional data on autologous hematopoietic stem cell transplantation in multiple sclerosis.
   Mult Scler. 2026 Aug 16:13524585261472335. doi: 10.1177/13524585261472335.
   PubMed        
   
   
8. WICKS T, Bergsland N, Zivadinov R, Weinstock-Guttman B, et al
   Impact of frailty on multiple sclerosis.
   Mult Scler. 2026 Aug 17:13524585261475090. doi: 10.1177/13524585261475090.
   PubMed         Abstract available
   
   
9. KOWALEC K, Manouchehrinia A, Kingwell E, Carruthers R, et al
   Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.
   Mult Scler. 2026 Aug 17:13524585261471335. doi: 10.1177/13524585261471335.
   PubMed         Abstract available
   
   
10. BEHAL A, Block VJ, Cree BA, Abbasi-Asl R, et al
    Diurnal step count patterns in progressive multiple sclerosis.
    Mult Scler. 2026 Aug 17:13524585261475910. doi: 10.1177/13524585261475910.
    PubMed         Abstract available
    
    
11. COTINAT M, Heesen C, Boudiaf I, Lederer C, et al
    Real-life walking speed: A new marker of progression in a primary progressive multiple sclerosis cohort study?
    Mult Scler. 2026 Aug 17:13524585261476543. doi: 10.1177/13524585261476543.
    PubMed         Abstract available
    
    
12. WEND-LAMITA KONSEIGA E, Maarouf A, Boutiere C, Demortiere S, et al
    Fatal cerebral toxoplasmosis in a patient with multiple sclerosis treated with natalizumab.
    Mult Scler. 2026 Aug 17:13524585261477217. doi: 10.1177/13524585261477217.
    PubMed         Abstract available
    
    
13. SUBERT M, Tykalova T, Novotny M, Srpova B, et al
    Automated speech analysis reveals progressive linguistic changes associated with subsequent gray matter loss in multiple sclerosis.
    Mult Scler. 2026 Aug 17:13524585261477213. doi: 10.1177/13524585261477213.
    PubMed         Abstract available
    
    
14. SMOOT K, Longbrake EE, Avila M, Wesley SF, et al
    Time-dependent divergence in infection risks among patients with multiple sclerosis treated with fumarates versus anti-CD20 monoclonal antibodies.
    Mult Scler. 2026 Aug 18:13524585261475232. doi: 10.1177/13524585261475232.
    PubMed         Abstract available
    
    

    
    Neurology

15. FERNANDEZ V, Pappolla A, Carbonell-Mirabent P, Castillo M, et al
    Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.
    Neurology. 2026;107:e218451.
    PubMed         Abstract available
    
    
16. GRANBERG T
    Paramagnetic Rim Lesions and Their Predictive Value of Future Progression in People With Multiple Sclerosis.
    Neurology. 2026;107:e218582.
    PubMed        
    
    
17. FURLAN R, Rossi E
    Longitudinal Neurofilament Light Chain Z-Score Dynamics: Bridging the Gap Between Research and Routine Monitoring in Multiple Sclerosis.
    Neurology. 2026;107:e218505.
    PubMed        
    
    
18. LAUERER M, Voon CC, McGinnis J, Sepp D, et al
    The Prognostic Value of Paramagnetic Rim Lesions in People With Multiple Sclerosis.
    Neurology. 2026;107:e218428.
    PubMed         Abstract available
    
    
19. SOLOMON AJ, Brownlee WJ, Viswanathan S, Fadda G, et al
    Application of the 2024 McDonald Criteria: Earlier Diagnosis and Avoiding Misdiagnosis of Multiple Sclerosis in a Global Setting.
    Neurology. 2026;107:e218425.
    PubMed         Abstract available
    
    

    
    PLoS One

20. TAUL-MADSEN L, Hvid LG, Casu G, Pau M, et al
    Protocol for a pilot effectiveness and feasibility randomized controlled trial of an advanced telerehabilitation system for people with multiple sclerosis (PLATINUMS project).
    PLoS One. 2026;21:e0355376.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum